HCM
CRDF icon

Highlander Capital Management’s Cardiff Oncology CRDF Stock Holding History

Highlander Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-28
Closed -$4K – 765
2016
Q4 		$4K Sell
28
-180
-87% -$42K ﹤0.01% 694
2016
Q3 		$67K Buy
208
+97
+87% +$35.4K 0.06% 299
2016
Q2 		$36K Sell
111
-97
-47% -$33.4K 0.03% 418
2016
Q1 		$70K Sell
208
-161
-44% -$54.8K 0.07% 290
2015
Q4 		$144K Hold
369
– – 0.13% 183
2015
Q3 		$151K Buy
369
+258
+232% +$135K 0.14% 180
2015
Q2 		$81K Buy
+111
New +$78.7K 0.07% 286

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return